Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 70518-4516

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 70518-4516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Lisinopril and Hydrochlorothiazide Tablets 10 mg / 12.5 mg oral tablets. The label indicates a quantity of 30 tablets, round white tablets marked H150. The product is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and a caution to keep medication out of reach of children are included, along with manufacturer information (Solco, Cranbury, NJ).*

FDA Label Image

Picture 1 (Image 01)

Chemical structure diagram of Lisinopril, an active ingredient in Lisinopril and Hydrochlorothiazide tablets. The structure includes molecular groups and bonds, representing the formula with identified elements such as nitrogen, oxygen, carbon, and hydrogen atoms.*

FDA Label Image

Picture 2 (Image 02)

Chemical structure of Lisinopril and Hydrochlorothiazide, the active ingredients in this oral tablet product, showing the detailed molecular arrangement including sulfur, nitrogen, oxygen, chlorine atoms, and ring structures.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.